A detailed history of Cetera Investment Advisers transactions in Fibrogen Inc stock. As of the latest transaction made, Cetera Investment Advisers holds 11,460 shares of FGEN stock, worth $5,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,460
Previous 12,055 4.94%
Holding current value
$5,730
Previous $10,000 60.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.33 - $1.26 $196 - $749
-595 Reduced 4.94%
11,460 $4,000
Q2 2024

Aug 22, 2024

BUY
$0.89 - $2.36 $529 - $1,404
595 Added 5.19%
12,055 $10,000
Q1 2024

May 24, 2024

BUY
$0.73 - $2.73 $8,365 - $31,285
11,460 New
11,460 $26,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $46.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.